These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21703032)

  • 1. The assessment of efficacy of porcine reproductive respiratory syndrome virus inactivated vaccine based on the viral quantity and inactivation methods.
    Kim H; Kim HK; Jung JH; Choi YJ; Kim J; Um CG; Hyun SB; Shin S; Lee B; Jang G; Kang BK; Moon HJ; Song DS
    Virol J; 2011 Jun; 8():323. PubMed ID: 21703032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the efficacy of autogenous inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccines with that of commercial vaccines against homologous and heterologous challenges.
    Geldhof MF; Vanhee M; Van Breedam W; Van Doorsselaere J; Karniychuk UU; Nauwynck HJ
    BMC Vet Res; 2012 Oct; 8():182. PubMed ID: 23031319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an experimental inactivated PRRSV vaccine that induces virus-neutralizing antibodies.
    Vanhee M; Delputte PL; Delrue I; Geldhof MF; Nauwynck HJ
    Vet Res; 2009; 40(6):63. PubMed ID: 19674539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivated porcine reproductive and respiratory syndrome virus vaccine adjuvanted with Montanide™ Gel 01 ST elicits virus-specific cross-protective inter-genotypic response in piglets.
    Tabynov K; Sansyzbay A; Tulemissova Z; Tabynov K; Dhakal S; Samoltyrova A; Renukaradhya GJ; Mambetaliyev M
    Vet Microbiol; 2016 Aug; 192():81-89. PubMed ID: 27527768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective humoral immune response induced by an inactivated porcine reproductive and respiratory syndrome virus expressing the hypo-glycosylated glycoprotein 5.
    Lee JA; Kwon B; Osorio FA; Pattnaik AK; Lee NH; Lee SW; Park SY; Song CS; Choi IS; Lee JB
    Vaccine; 2014 Jun; 32(29):3617-22. PubMed ID: 24814552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody response and maternal immunity upon boosting PRRSV-immune sows with experimental farm-specific and commercial PRRSV vaccines.
    Geldhof MF; Van Breedam W; De Jong E; Lopez Rodriguez A; Karniychuk UU; Vanhee M; Van Doorsselaere J; Maes D; Nauwynck HJ
    Vet Microbiol; 2013 Dec; 167(3-4):260-71. PubMed ID: 24041768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a novel inactivated PRRS virus vaccine on virus replication and virus-induced pathology in fetal implantation sites and fetuses upon challenge.
    Karniychuk UU; Saha D; Vanhee M; Geldhof M; Cornillie P; Caij AB; De Regge N; Nauwynck HJ
    Theriogenology; 2012 Oct; 78(7):1527-37. PubMed ID: 22980086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An interferon inducing porcine reproductive and respiratory syndrome virus vaccine candidate elicits protection against challenge with the heterologous virulent type 2 strain VR-2385 in pigs.
    Fontanella E; Ma Z; Zhang Y; de Castro AM; Shen H; Halbur PG; Opriessnig T
    Vaccine; 2017 Jan; 35(1):125-131. PubMed ID: 27876202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of commercial genotype 1 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine against field isolate of genotype 2 PRRSV.
    Ko SS; Seo SW; Sunwoo SY; Yoo SJ; Kim MH; Lyoo YS
    Vet Immunol Immunopathol; 2016 Apr; 172():43-9. PubMed ID: 27032502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A porcine reproductive and respiratory syndrome virus candidate vaccine based on the synthetic attenuated virus engineering approach is attenuated and effective in protecting against homologous virus challenge.
    Evenson D; Gerber PF; Xiao CT; Halbur PG; Wang C; Tian D; Ni YY; Meng XJ; Opriessnig T
    Vaccine; 2016 Nov; 34(46):5546-5553. PubMed ID: 27742217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a DNA-launched replicon as a vaccine for porcine reproductive and respiratory syndrome virus.
    Pujhari S; Baig TT; Hansra S; Zakhartchouk AN
    Virus Res; 2013 May; 173(2):321-6. PubMed ID: 23353778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive inductive effect of swine interleukin-4 on immune responses elicited by modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine.
    Peng J; Wang J; Wu J; Du Y; Li J; Guo Z; Yu J; Xu S; Zhang Y; Sun W; Cong X; Shi J
    Viral Immunol; 2013 Dec; 26(6):404-14. PubMed ID: 24328935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a killed porcine reproductive and respiratory syndrome virus (PRRSV) vaccine treatment on virus shedding in previously PRRSV infected pigs.
    Nilubol D; Platt KB; Halbur PG; Torremorell M; Harris DL
    Vet Microbiol; 2004 Aug; 102(1-2):11-8. PubMed ID: 15288922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant Porcine Interferon Alpha Enhances Immune Responses to Killed Porcine Reproductive and Respiratory Syndrome Virus Vaccine in Pigs.
    Yu HY; Qu MS; Zhang JL; Gan L; Zhao Y; Shan XQ; Zhou W; Xia BB; Chen J; Wang ML; Zhao J
    Viral Immunol; 2019 Nov; 32(9):383-392. PubMed ID: 31693458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a combined inactivated porcine reproductive and respiratory syndrome virus vaccine using North American and European strains in specific pathogen free pigs.
    Yeom M; Lyoo KS; Kang BK; Song D; Park B
    Vet J; 2015 May; 204(2):157-61. PubMed ID: 25920759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral immune responses and viral shedding following vaccination with modified live porcine reproductive and respiratory syndrome virus vaccines.
    Madapong A; Temeeyasen G; Saeng-Chuto K; Tripipat T; Navasakuljinda W; Boonsoongnern A; Tantituvanont A; Nilubol D
    Arch Virol; 2017 Jan; 162(1):139-146. PubMed ID: 27695957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ability of ELISAs to detect antibodies against porcine respiratory and reproductive syndrome virus in serum of pigs after inactivated vaccination and subsequent challenge.
    Sattler T; Pikalo J; Wodak E; Schmoll F
    BMC Vet Res; 2016 Nov; 12(1):259. PubMed ID: 27871292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of an inactivated vaccine against porcine reproductive and respiratory syndrome to protect gilts against a heterologous challenge with PRRSV.
    Scortti M; Prieto C; Alvarez E; Simarro I; Castro JM
    Vet Rec; 2007 Dec; 161(24):809-13. PubMed ID: 18083979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain.
    Martelli P; Cordioli P; Alborali LG; Gozio S; De Angelis E; Ferrari L; Lombardi G; Borghetti P
    Vaccine; 2007 Apr; 25(17):3400-8. PubMed ID: 17276558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pigs immunized with Chinese highly pathogenic PRRS virus modified live vaccine are protected from challenge with North American PRRSV strain NADC-20.
    Galliher-Beckley A; Li X; Bates JT; Madera R; Waters A; Nietfeld J; Henningson J; He D; Feng W; Chen R; Shi J
    Vaccine; 2015 Jul; 33(30):3518-25. PubMed ID: 26049004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.